Miranda, Marvelyn .

HRN: 23-80-66  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/30/2024
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
06/30/2024
07/03/2024
IV
500mg
Q8 X 6 Doses
AGE With Moderate Dehydration
Waiting Final Action 
09/02/2024
CEFUROXIME 500MG (TAB)
09/02/2024
09/08/2024
PO
500mg
BID
Rmle
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: